rethinkPeptides Search
Menu
Study breakdown

Why HIV's Fusion Peptide Sequence Is So Conserved: NMR Reveals Sequence Order Matters More Than Hydrophobicity

evidence
The takeaway

NMR structural analysis shows that the HIV-1 fusion peptide's highly conserved FLGFLG sequence maintains its helical structure and ability to form trimers in membranes — properties lost when the same amino acids are scrambled, proving sequence order is critical beyond mere hydrophobicity.

Absolutely conserved FLGFLG

The tandem FLGFLG repeat in HIV's fusion peptide is conserved across all strains because scrambling these same amino acids destroys the membrane helical structure and trimerization essential for viral entry.

What the researchers found

Two fusion peptide surrogates with equal hydrophobicity but different sequences were compared:

- wtFP-tag (wild-type LFLGFLG): preserved α-helical conformation with a Gly-rich ridge in DPC micelles (membrane mimic); assembled into trimers in membranes (detected by Western blot)

- scrFP-tag (scrambled FGLLGFL): maintained helical structure in low-polarity HFIP solvent but largely lost helical structure in DPC micelles; failed to form membrane oligomers

Both peptides were tagged with an independently folding epitope sequence for detection without interfering with FP structure. The results demonstrate that the conserved FLGFLG tandem repeat is essential for maintaining the specific helical conformation and trimerization ability required for HIV membrane fusion.

Why it matters

Understanding why HIV's fusion peptide sequence is so conserved reveals a potential vulnerability for drug and vaccine design. If the virus cannot tolerate changes to this sequence without losing function, then therapies targeting this exact peptide region may be broadly effective against diverse HIV strains. The finding that sequence order (not just hydrophobicity) determines membrane structure and trimerization provides specific structural features that could be exploited by fusion inhibitor drugs or antibodies targeting the fusion peptide.

How the study worked

Wild-type and scrambled HIV fusion peptide variants were synthesized with C-terminal epitope tags. NMR spectroscopy was used to determine three-dimensional structures in two environments: 25% HFIP (nonpolar solvent) and DPC micelles (membrane-mimicking system). Secondary structure content, helical features, and glycine-ridge characteristics were compared between the two sequences. Western blot analysis using the epitope tags assessed oligomerization (trimerization) in membrane environments.

What this study cannot tell us

The study used synthetic peptide surrogates rather than full-length gp41 protein, which may not perfectly replicate the fusion peptide's behavior in the context of the complete viral spike. DPC micelles are simplified membrane mimics that lack the complexity of biological membranes. Only one scrambled sequence was tested — other permutations might retain more function. The study did not directly test viral infectivity with modified fusion peptides. The epitope tag, while designed to fold independently, could potentially influence some structural measurements.

How to read the evidence

This is a structural biology study using NMR spectroscopy — a gold-standard technique for determining peptide conformations in solution. The comparison of wild-type versus scrambled sequences with matched hydrophobicity is a well-controlled experimental design. However, the findings are in model membrane systems, not intact virus or cells.

When this study was published

Published in 2017, this study is about 8 years old. Research on fusion peptide-targeted HIV vaccines and broadly neutralizing antibodies has advanced significantly since then, building on structural insights like those presented here.

The bigger picture

HIV fusion peptide-targeting broadly neutralizing antibodies (like VRC34) are among the most promising leads for a universal HIV vaccine. This structural study explains why these antibodies can be broadly effective — the fusion peptide sequence is absolutely conserved because any change destroys the precise structure needed for membrane fusion. Understanding the structural basis of this conservation strengthens the rationale for fusion peptide-targeted vaccine strategies and could guide the design of new fusion inhibitor drugs.

Questions still open

  • Could fusion peptide-targeted drugs exploit the strict sequence dependence to create broadly effective HIV entry inhibitors?
  • Does the glycine-rich ridge identified by NMR represent a specific structural epitope for broadly neutralizing antibodies?
  • Would mutations that disrupt trimerization but preserve helicity still allow some degree of viral entry?

Common questions

What is the HIV fusion peptide and why does it matter?
The fusion peptide is a short stretch of amino acids at the tip of HIV's envelope protein that physically punches into the host cell membrane to initiate infection. It's one of the most conserved parts of HIV — meaning the virus can't easily change it without losing the ability to infect cells. This makes it an attractive target for vaccines and drugs that could work against all HIV strains.
Why can't HIV change this peptide to escape drugs or vaccines?
This study shows that the specific order of amino acids in the fusion peptide (FLGFLG) is essential for forming the right 3D shape in cell membranes and assembling into trimers — both required for viral entry. When the same amino acids are rearranged, the peptide loses its structure and can't trimerize. The virus is essentially trapped: it needs this exact sequence to function, making it a reliable drug and vaccine target.

Read the original research

Structure-Related Roles for the Conservation of the HIV-1 Fusion Peptide Sequence Revealed by Nuclear Magnetic Resonance.

Biochemistry, 56(41), 5503-5511

Citation

Serrano, Soraya; Huarte, Nerea; Rujas, Edurne; Andreu, David; Nieva, José L; Jiménez, María Angeles. (2017). Structure-Related Roles for the Conservation of the HIV-1 Fusion Peptide Sequence Revealed by Nuclear Magnetic Resonance.. Biochemistry, 56(41), 5503-5511. https://doi.org/10.1021/acs.biochem.7b00745